NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Domain Associates’

29 December 2014

Domain Associates scores $163m in first fundraise since 2009

santarus life sciences Life sciences-focused Domain Associates has pulled in $163.6m for its ninth venture capital fund.

24 November 2014

Legend, Novartis lead $53m round in BioNano Genomics

syringe-m Legend Capital and Novartis Venture Fund have led a $53m Series C financing round in genome mapping company BioNano Genomics.

15 July 2014

Domain-backed molecular diagnostic business Xagenic seals $25.5m Series B

Xagenic Venture capital-backed molecular diagnostics company Xagenic has upped its Series B round to $25.5m through a new investment from BDC Capital.

28 April 2014

Life sciences investor Domain Elite inks first deal in China’s Smart Medical

Life sciences investor Domain Elite has made its first investment in Smart Medical Systems, a Chinese developer and manufacturer of endoscopy and colonoscopy products.

9 April 2014

Delphi Ventures leads new funding round for Sequent Medical

brain_lrg Delphi Ventures has recommitted to portfolio company Sequent Medical by leading a $20m Series D financing round.

12 February 2014

VC backed Cadence Pharmaceuticals sells for $1.3bn

NYSE-listed pharmaceuticals company Mallinckrodt has agreed to acquire VC-backed Cadence Pharmaceuticals for $1.3bn.

22 January 2014

Venture capital-backed Dicerna prices IPO at $11 to $13 per share

dna Venture capital-backed RNA interference-based therapeutics developer Dicerna Pharmaceuticals has priced its IPO at $11 to $13 per share.

17 December 2013

Amgen Ventures joins KPCB, others backing $38.5m Series B for drug developer Atara

Thrasos Therapeutics kidney - AltAssets Private Equity News Amgen Ventures is among the new investors committing capital to drug development company Atara Therapeutics as part of a $38.5m Series B financing round.

3 December 2013

Molecular diagnostics company Xagenic raises $20m Series B

Panasonic HealthcareToronto-based molecular diagnostics company Xagenic has secured $20m in a Series B round led by new investor Domain Associates.

14 November 2013

Insulin pump maker Tandem Diabetes Care surges after IPO

stock brokerage market share listed Venture capital-backed Tandem Diabetes Care surged after its IPO on the Nasdaq exchange, which valued the medical devices company at $15 per share.

Page 1 of 212

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015